Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2006-08-13 10:47:12 UTC |
---|
Update Date | 2023-02-21 17:16:55 UTC |
---|
HMDB ID | HMDB0004095 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | 5-Methoxytryptamine |
---|
Description | 5-Methoxytryptamine, also known as mexamine or 5-MT, belongs to the class of organic compounds known as tryptamines and derivatives. Tryptamines and derivatives are compounds containing the tryptamine backbone, which is structurally characterized by an indole ring substituted at the 3-position by an ethanamine. It is biosynthesized via the deacetylation of melatonin in the pineal gland. 5-MT acts as a full agonist at the 5-HT1, 5-HT2, 5-HT4, 5-HT6, and 5-HT7 receptors. 5-Methoxytryptamine exists in all living organisms, ranging from bacteria to humans. Its affinity for the 5-HT5A receptor is unknown. It has no affinity for the 5-HT3 receptor and is affinity for the 5-HT1E receptor is very weak in comparison to the other 5-HT1 receptors. 5-MT has been shown to occur naturally in the body in low levels. |
---|
Structure | InChI=1S/C11H14N2O/c1-14-9-2-3-11-10(6-9)8(4-5-12)7-13-11/h2-3,6-7,13H,4-5,12H2,1H3 |
---|
Synonyms | Value | Source |
---|
2-(5-Methoxyindol-3-yl)ethylamine | ChEBI | 3-(2-Aminoethyl)-5-methoxyindole | ChEBI | 5-MeOT | ChEBI | 5-Methoxy-1H-indole-3-ethanamine | ChEBI | 5-MT | ChEBI | 5MOT | ChEBI | Mexamine | ChEBI | 2-(5-Methoxy-1H-indol-3-yl)ethanamine | HMDB | 5-Mot | HMDB | Lopac-m-6628 | HMDB | Meksamin | HMDB | Methoxytryptamine | HMDB | Mexamine base | HMDB | Meksamine | HMDB | 5 Methoxytryptamine | HMDB | 5-Methoxytryptamine | ChEBI |
|
---|
Chemical Formula | C11H14N2O |
---|
Average Molecular Weight | 190.2417 |
---|
Monoisotopic Molecular Weight | 190.11061308 |
---|
IUPAC Name | 2-(5-methoxy-1H-indol-3-yl)ethan-1-amine |
---|
Traditional Name | 5 methoxytryptamine |
---|
CAS Registry Number | 608-07-1 |
---|
SMILES | COC1=CC2=C(NC=C2CCN)C=C1 |
---|
InChI Identifier | InChI=1S/C11H14N2O/c1-14-9-2-3-11-10(6-9)8(4-5-12)7-13-11/h2-3,6-7,13H,4-5,12H2,1H3 |
---|
InChI Key | JTEJPPKMYBDEMY-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as tryptamines and derivatives. Tryptamines and derivatives are compounds containing the tryptamine backbone, which is structurally characterized by an indole ring substituted at the 3-position by an ethanamine. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Indoles and derivatives |
---|
Sub Class | Tryptamines and derivatives |
---|
Direct Parent | Tryptamines and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Tryptamine
- 3-alkylindole
- Indole
- Anisole
- 2-arylethylamine
- Alkyl aryl ether
- Aralkylamine
- Substituted pyrrole
- Benzenoid
- Heteroaromatic compound
- Pyrrole
- Ether
- Azacycle
- Hydrocarbon derivative
- Organic nitrogen compound
- Primary amine
- Organooxygen compound
- Organonitrogen compound
- Primary aliphatic amine
- Organopnictogen compound
- Organic oxygen compound
- Amine
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 121.5 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
5-Methoxytryptamine,1TMS,isomer #1 | COC1=CC=C2[NH]C=C(CCN[Si](C)(C)C)C2=C1 | 2089.1 | Semi standard non polar | 33892256 | 5-Methoxytryptamine,1TMS,isomer #1 | COC1=CC=C2[NH]C=C(CCN[Si](C)(C)C)C2=C1 | 2183.0 | Standard non polar | 33892256 | 5-Methoxytryptamine,1TMS,isomer #1 | COC1=CC=C2[NH]C=C(CCN[Si](C)(C)C)C2=C1 | 2684.6 | Standard polar | 33892256 | 5-Methoxytryptamine,1TMS,isomer #2 | COC1=CC=C2C(=C1)C(CCN)=CN2[Si](C)(C)C | 2038.7 | Semi standard non polar | 33892256 | 5-Methoxytryptamine,1TMS,isomer #2 | COC1=CC=C2C(=C1)C(CCN)=CN2[Si](C)(C)C | 2098.4 | Standard non polar | 33892256 | 5-Methoxytryptamine,1TMS,isomer #2 | COC1=CC=C2C(=C1)C(CCN)=CN2[Si](C)(C)C | 2652.5 | Standard polar | 33892256 | 5-Methoxytryptamine,2TMS,isomer #1 | COC1=CC=C2C(=C1)C(CCN[Si](C)(C)C)=CN2[Si](C)(C)C | 2141.6 | Semi standard non polar | 33892256 | 5-Methoxytryptamine,2TMS,isomer #1 | COC1=CC=C2C(=C1)C(CCN[Si](C)(C)C)=CN2[Si](C)(C)C | 2241.4 | Standard non polar | 33892256 | 5-Methoxytryptamine,2TMS,isomer #1 | COC1=CC=C2C(=C1)C(CCN[Si](C)(C)C)=CN2[Si](C)(C)C | 2437.9 | Standard polar | 33892256 | 5-Methoxytryptamine,2TMS,isomer #2 | COC1=CC=C2[NH]C=C(CCN([Si](C)(C)C)[Si](C)(C)C)C2=C1 | 2276.6 | Semi standard non polar | 33892256 | 5-Methoxytryptamine,2TMS,isomer #2 | COC1=CC=C2[NH]C=C(CCN([Si](C)(C)C)[Si](C)(C)C)C2=C1 | 2369.7 | Standard non polar | 33892256 | 5-Methoxytryptamine,2TMS,isomer #2 | COC1=CC=C2[NH]C=C(CCN([Si](C)(C)C)[Si](C)(C)C)C2=C1 | 2582.0 | Standard polar | 33892256 | 5-Methoxytryptamine,3TMS,isomer #1 | COC1=CC=C2C(=C1)C(CCN([Si](C)(C)C)[Si](C)(C)C)=CN2[Si](C)(C)C | 2361.1 | Semi standard non polar | 33892256 | 5-Methoxytryptamine,3TMS,isomer #1 | COC1=CC=C2C(=C1)C(CCN([Si](C)(C)C)[Si](C)(C)C)=CN2[Si](C)(C)C | 2438.0 | Standard non polar | 33892256 | 5-Methoxytryptamine,3TMS,isomer #1 | COC1=CC=C2C(=C1)C(CCN([Si](C)(C)C)[Si](C)(C)C)=CN2[Si](C)(C)C | 2401.3 | Standard polar | 33892256 | 5-Methoxytryptamine,1TBDMS,isomer #1 | COC1=CC=C2[NH]C=C(CCN[Si](C)(C)C(C)(C)C)C2=C1 | 2382.1 | Semi standard non polar | 33892256 | 5-Methoxytryptamine,1TBDMS,isomer #1 | COC1=CC=C2[NH]C=C(CCN[Si](C)(C)C(C)(C)C)C2=C1 | 2371.7 | Standard non polar | 33892256 | 5-Methoxytryptamine,1TBDMS,isomer #1 | COC1=CC=C2[NH]C=C(CCN[Si](C)(C)C(C)(C)C)C2=C1 | 2742.5 | Standard polar | 33892256 | 5-Methoxytryptamine,1TBDMS,isomer #2 | COC1=CC=C2C(=C1)C(CCN)=CN2[Si](C)(C)C(C)(C)C | 2280.9 | Semi standard non polar | 33892256 | 5-Methoxytryptamine,1TBDMS,isomer #2 | COC1=CC=C2C(=C1)C(CCN)=CN2[Si](C)(C)C(C)(C)C | 2266.9 | Standard non polar | 33892256 | 5-Methoxytryptamine,1TBDMS,isomer #2 | COC1=CC=C2C(=C1)C(CCN)=CN2[Si](C)(C)C(C)(C)C | 2707.7 | Standard polar | 33892256 | 5-Methoxytryptamine,2TBDMS,isomer #1 | COC1=CC=C2C(=C1)C(CCN[Si](C)(C)C(C)(C)C)=CN2[Si](C)(C)C(C)(C)C | 2618.0 | Semi standard non polar | 33892256 | 5-Methoxytryptamine,2TBDMS,isomer #1 | COC1=CC=C2C(=C1)C(CCN[Si](C)(C)C(C)(C)C)=CN2[Si](C)(C)C(C)(C)C | 2628.5 | Standard non polar | 33892256 | 5-Methoxytryptamine,2TBDMS,isomer #1 | COC1=CC=C2C(=C1)C(CCN[Si](C)(C)C(C)(C)C)=CN2[Si](C)(C)C(C)(C)C | 2613.4 | Standard polar | 33892256 | 5-Methoxytryptamine,2TBDMS,isomer #2 | COC1=CC=C2[NH]C=C(CCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2=C1 | 2733.4 | Semi standard non polar | 33892256 | 5-Methoxytryptamine,2TBDMS,isomer #2 | COC1=CC=C2[NH]C=C(CCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2=C1 | 2747.1 | Standard non polar | 33892256 | 5-Methoxytryptamine,2TBDMS,isomer #2 | COC1=CC=C2[NH]C=C(CCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2=C1 | 2696.8 | Standard polar | 33892256 | 5-Methoxytryptamine,3TBDMS,isomer #1 | COC1=CC=C2C(=C1)C(CCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CN2[Si](C)(C)C(C)(C)C | 2985.7 | Semi standard non polar | 33892256 | 5-Methoxytryptamine,3TBDMS,isomer #1 | COC1=CC=C2C(=C1)C(CCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CN2[Si](C)(C)C(C)(C)C | 2962.0 | Standard non polar | 33892256 | 5-Methoxytryptamine,3TBDMS,isomer #1 | COC1=CC=C2C(=C1)C(CCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CN2[Si](C)(C)C(C)(C)C | 2673.7 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - 5-Methoxytryptamine GC-MS (2 TMS) | splash10-0ue9-1960000000-9d22140ff2b48f31db09 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - 5-Methoxytryptamine GC-MS (2 TMS) | splash10-00dr-3900000000-b121de7d00a382123401 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - 5-Methoxytryptamine GC-MS (Non-derivatized) | splash10-0ue9-1960000000-9d22140ff2b48f31db09 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - 5-Methoxytryptamine GC-MS (Non-derivatized) | splash10-00dr-3900000000-b121de7d00a382123401 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - 5-Methoxytryptamine GC-EI-TOF (Non-derivatized) | splash10-00dr-2900000000-a5fe7e3acae8eed474de | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - 5-Methoxytryptamine GC-EI-TOF (Non-derivatized) | splash10-00di-2900000000-2b80fe48b74acca6bebf | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Methoxytryptamine GC-MS (Non-derivatized) - 70eV, Positive | splash10-001i-6900000000-c9d325a89238b38270a6 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Methoxytryptamine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methoxytryptamine Quattro_QQQ 10V, Negative-QTOF (Annotated) | splash10-00dr-0900000000-ac5e7141a1f9a408fc34 | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methoxytryptamine Quattro_QQQ 25V, Negative-QTOF (Annotated) | splash10-0006-0900000000-6e5b3b429a1bb70ffaf4 | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methoxytryptamine Quattro_QQQ 40V, Negative-QTOF (Annotated) | splash10-0006-0900000000-e60ae04a11b9e498a966 | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methoxytryptamine LC-ESI-QQ (API3000, Applied Biosystems) 10V, Negative-QTOF | splash10-000i-0900000000-54e5a7201f25456dcad8 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methoxytryptamine LC-ESI-QQ (API3000, Applied Biosystems) 20V, Negative-QTOF | splash10-00di-1900000000-293475115ff46b97099a | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methoxytryptamine LC-ESI-QQ (API3000, Applied Biosystems) 30V, Negative-QTOF | splash10-0006-1900000000-66f8cb9c260ecf410ce1 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methoxytryptamine LC-ESI-QQ (API3000, Applied Biosystems) 40V, Negative-QTOF | splash10-0006-1900000000-a14a529194c5227e34f8 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methoxytryptamine LC-ESI-QQ (API3000, Applied Biosystems) 50V, Negative-QTOF | splash10-002f-0900000000-ad73b33b853950cd5689 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methoxytryptamine LC-ESI-QQ , negative-QTOF | splash10-000i-0900000000-54e5a7201f25456dcad8 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methoxytryptamine LC-ESI-QQ , negative-QTOF | splash10-00di-1900000000-adf7f816d92642625bdd | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methoxytryptamine LC-ESI-QQ , negative-QTOF | splash10-0006-1900000000-66f8cb9c260ecf410ce1 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methoxytryptamine LC-ESI-QQ , negative-QTOF | splash10-0006-1900000000-a14a529194c5227e34f8 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methoxytryptamine LC-ESI-QQ , negative-QTOF | splash10-002f-0900000000-ad73b33b853950cd5689 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methoxytryptamine Linear Ion Trap , negative-QTOF | splash10-00di-0900000000-485d7582e65bfa3e31f1 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methoxytryptamine Linear Ion Trap , negative-QTOF | splash10-00di-0900000000-db26f9e0d37f5c251c53 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methoxytryptamine Linear Ion Trap , negative-QTOF | splash10-00di-0900000000-eaf537b355550eb27e55 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methoxytryptamine Linear Ion Trap , negative-QTOF | splash10-00di-0900000000-478e855c47b694b99c9c | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methoxytryptamine 20V, Negative-QTOF | splash10-0006-0900000000-3096f67fc0f5797d14b7 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methoxytryptamine 10V, Negative-QTOF | splash10-00di-0900000000-2d015296f43e86be7b7e | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methoxytryptamine 40V, Negative-QTOF | splash10-0006-0900000000-2a2466c60f7faa96dcca | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methoxytryptamine LC-ESI-QQ (API3000, Applied Biosystems) 10V, Positive-QTOF | splash10-00di-0900000000-c4f465460bde21d469be | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methoxytryptamine LC-ESI-QQ (API3000, Applied Biosystems) 20V, Positive-QTOF | splash10-00di-0900000000-f1d40ff7aa6c88ecdfd5 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methoxytryptamine LC-ESI-QQ (API3000, Applied Biosystems) 30V, Positive-QTOF | splash10-05fr-0900000000-22d3b9e8cbdb136bcb64 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methoxytryptamine LC-ESI-QQ (API3000, Applied Biosystems) 40V, Positive-QTOF | splash10-001i-0900000000-74e1867f5b88bc53f677 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methoxytryptamine LC-ESI-QQ (API3000, Applied Biosystems) 50V, Positive-QTOF | splash10-001i-0900000000-438c89f58ad3c0098959 | 2012-08-31 | HMDB team, MONA | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, experimental) | 2012-12-05 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|
General References | - Geffard M, Dulluc J, Rock AM: Antisera against the indolealkylamines: tryptophan, 5-hydroxytryptophan, 5-hydroxytryptamine, 5-methoxytryptophan, and 5-methoxytryptamine tested by an enzyme-linked immunosorbent assay method. J Neurochem. 1985 Apr;44(4):1221-8. [PubMed:3919158 ]
- Rom-Bugolavskaia ES, Shcherbakova VS, Komarova IV: [The effect of melatonin and mexamine on the human thyroid under in-vitro conditions]. Eksp Klin Farmakol. 1997 Jul-Aug;60(4):46-9. [PubMed:9376758 ]
- Kirchheiner J, Henckel HB, Franke L, Meineke I, Tzvetkov M, Uebelhack R, Roots I, Brockmoller J: Impact of the CYP2D6 ultra-rapid metabolizer genotype on doxepin pharmacokinetics and serotonin in platelets. Pharmacogenet Genomics. 2005 Aug;15(8):579-87. [PubMed:16007002 ]
- Romsing S, Bokman F, Bergqvist Y: Determination of melatonin in saliva using automated solid-phase extraction, high-performance liquid chromatography and fluorescence detection. Scand J Clin Lab Invest. 2006;66(3):181-90. [PubMed:16714247 ]
|
---|